More than 26,000 hernia mesh lawsuits remain pending in federal court as of December 2025, concentrated across four manufacturer-specific proceedings. The current status of the hernia mesh lawsuits splits cleanly in two: C.R. Bard’s litigation, by far the largest, is being resolved through a global settlement that Becton, Dickinson and Company announced in October 2024, while the Covidien proceeding has become the most active forum for new and ongoing claims. The Ethicon and Atrium dockets are effectively winding down.
Where Each MDL Stands
Federal hernia mesh cases are grouped into multidistrict litigations, which let one judge handle pretrial work for thousands of similar claims. Four MDLs exist, and they are at very different points.
- C.R. Bard / Davol (MDL-2846). Roughly 23,800 cases pending in the Southern District of Ohio. BD announced a global settlement in October 2024 covering the federal MDL and consolidated state cases in Rhode Island. Payouts roll out over several years.
- Covidien (MDL-3029). About 2,260 cases pending as of early 2026. This is the most active proceeding still in earlier stages, with significant runway ahead for new filings.
- Atrium Medical (MDL-2753). Roughly 320 cases remain. Atrium set aside more than $66 million in 2021 to resolve claims, and the docket has been shrinking steadily.
- Ethicon (MDL-2782). Essentially zero active cases. Most Physiomesh claims have been individually resolved or sent back to their home courts.
The combined federal caseload across all four MDLs stood at roughly 26,400 as of December 2025. That number moves as cases settle, are dismissed, or are remanded.
The Bard Global Settlement
BD’s October 2024 announcement covers the vast majority of its hernia mesh litigation, including both the Ohio federal MDL and the Rhode Island state court consolidation. The company stated the total payout falls within its existing litigation reserves. Independent reports have placed the aggregate figure above $1 billion across more than 38,000 claims.
Individual payouts vary dramatically because the settlement uses a tiered, points-based structure keyed to documented injury severity. Claimants who received a Bard mesh but cannot document a qualifying injury receive a minimal payment. Mild-to-moderate complications supported by medical records, such as a single revision surgery, qualify for a mid-tier payment. The highest payouts go to plaintiffs with severe injuries like multiple surgeries, permanent disability, or organ damage backed by comprehensive documentation. Number of revision surgeries and the quality of supporting records drive the point total.
New claimants may still be able to participate depending on timing and qualification. That window is a question for an attorney reviewing your records against the settlement’s eligibility criteria, not something that can be answered in the abstract.
The Bellwether Verdicts That Preceded the Settlement
Before settling, BD lost all three bellwether trials in the Bard MDL between 2022 and 2023. Juries use these representative cases to give both sides real feedback on the evidence, and the results shape what remaining cases are worth.
- April 2022: A federal jury in Ohio returned a $255,000 verdict against C.R. Bard involving a Ventralex hernia patch, including $5,000 for loss of consortium.
- August 2022: A Rhode Island jury awarded $4.8 million against a C.R. Bard subsidiary, the largest individual hernia mesh verdict to date.
- November 2023: A federal jury ordered Bard to pay $500,000 to a plaintiff who received an extra-large PerFix Plug mesh in 2015.
Ethicon and Atrium have resolved cases through confidential settlements, so public verdict data for those manufacturers is limited.
Which Products and Manufacturers Are Involved
Four manufacturers account for nearly all current hernia mesh litigation, each tied to specific product lines.
C.R. Bard / Davol (Becton, Dickinson)
Bard’s polypropylene products are the most heavily litigated: PerFix Plug, 3DMax, Ventralex, Ventralight, Kugel, and Composix. The Composix Kugel mesh was the subject of a Class 1 FDA recall in 2006, the most serious recall classification, after reports that the ring stiffener could break and perforate bowel tissue. Allegations across the product line focus on polypropylene degradation, chronic inflammatory reactions, and failure to warn surgeons about known risks.
Covidien (Medtronic)
Covidien’s Parietex and Symbotex mesh products are the focus of the newest and second-largest active MDL. Plaintiffs allege the protective coating on Symbotex mesh breaks down prematurely after implantation, exposing tissue to the underlying polypropylene and causing adhesions, infections, and chronic pain.
Ethicon (Johnson & Johnson)
Physiomesh Flexible Composite Mesh drew most Ethicon claims. In May 2016, Ethicon issued an urgent global market withdrawal after data from large hernia registries in Germany and Denmark showed higher-than-expected rates of hernia recurrence and revision surgery compared to other mesh products. The Proceed Surgical Mesh was subject to a Class 2 FDA recall in 2014. With the Ethicon MDL now essentially resolved, few active claims remain.
Atrium Medical
Atrium’s C-Qur mesh uses an Omega-3 fatty acid coating designed to reduce adhesion. Lawsuits allege the coating triggers severe inflammatory reactions and infections. The litigation is winding down.
Who Qualifies to File
Eligibility turns on two things. You received a hernia mesh product from one of the manufacturers being sued, and you developed complications beyond the normal risks of surgery. Qualifying injuries include chronic pain, infection, mesh migration, bowel obstruction, organ perforation, hernia recurrence, or the need for revision surgery to remove or replace the mesh. The stronger the documented link between the specific mesh product and your complications, the stronger the claim.
The single most important document is the surgical report from your original hernia repair, which identifies the exact mesh brand and model. Without that, matching your case to the correct MDL is difficult. Hospital discharge summaries, follow-up notes, imaging, and records from any revision surgery all build on that foundation.
If the hospital or surgeon’s practice has closed, the records still exist somewhere. Hospitals where the surgeon held admitting privileges often retain records for affiliated physicians. County medical societies sometimes maintain databases of closed practices and can point you toward the records custodian. Medical record retrieval specialists can also track down files from defunct practices for a fee. Having your full name, date of birth, and approximate treatment dates ready speeds up any request.
Filing Deadlines Are the Hard Limit
Every state imposes a statute of limitations on personal injury claims. Deadlines for hernia mesh lawsuits vary significantly: some states allow as little as one year from the date of injury, others up to six. Missing the deadline almost always bars the claim permanently, regardless of its merits.
Medical device injuries often surface years after implantation, and most states address this through a discovery rule. The clock starts when you knew or reasonably should have known that your injury was connected to the mesh, not when the mesh was implanted. If chronic pain in 2024 was not linked to a 2018 implant until a doctor flagged it in 2025, many states would start the filing deadline from 2025.
The discovery rule has limits. Some states impose a statute of repose, a hard outer deadline that cuts off claims after a fixed number of years from the product’s sale no matter when the injury was discovered. Whether you are inside or outside both deadlines is the first question an attorney will work through on an initial call.
What a Settlement Actually Covers
Hernia mesh settlements and verdicts compensate several categories of harm. Medical expenses cover past treatment, revision surgeries, hospital stays, therapy, imaging, and future care. Lost income covers wages missed during recovery as well as reduced earning capacity when complications force a shift to less demanding, lower-paying work. Pain and suffering accounts for the physical pain of the defective mesh and its complications. Mental anguish covers psychological harm like anxiety or depression tied to ongoing health problems. Some claims add loss of enjoyment of life when complications prevent activities that were part of daily routine before the implant. The Bard bellwether trials also included loss of consortium claims for affected spouses.
The Bard global settlement shows how widely individual payouts vary. The gap between a minimal payment and a six-figure recovery comes down almost entirely to what medical records show about injury severity, number of surgeries, and long-term impact.
One caution on net recovery: if Medicare paid for any mesh-related treatment, federal law requires reimbursement from your settlement, and your attorney must notify the Benefits Coordination and Recovery Center. Medicaid operates similarly, though federal law limits state recovery to the portion of a settlement that represents past medical expenses paid by Medicaid. Portions allocated to pain and suffering, lost wages, and other non-medical damages are protected. Understanding these liens before accepting a settlement prevents surprises when the net figure arrives.
Pursuing a Claim From Here
Start with an attorney who handles mass tort or medical device litigation. Most work on contingency, collecting a percentage of recovery rather than billing hourly. Contingency fees in mass tort cases typically run around 33% but can range from 20% to 40% depending on complexity and how far the case progresses before resolution. Litigation costs like filing fees, expert witness fees, and medical record retrieval come out of the settlement separately. Whether those costs are deducted before or after the attorney’s percentage is calculated depends on your fee agreement, which is worth reading closely before signing.
After the initial consultation, the legal team will request medical records, identify the mesh product, and determine which proceeding your case belongs in. For Bard claims, that means evaluating fit against the global settlement’s qualification criteria. For Covidien, it means building an individual case in a proceeding where discovery and bellwether selection still lie ahead. From filing, cases enter discovery, then either settle through negotiation or move toward trial, though the overwhelming majority of mass tort claims resolve without a jury ever hearing them.